Your Brain Produces DMT: The Endogenous DMT Theory Explained | Self Growth Videos
Dimethyltryptamine is a Schedule I controlled substance. It is also produced by your own body.
This is not a fringe claim. DMT has been detected in human blood, urine, cerebrospinal fluid, and lung tissue in multiple studies conducted over several decades. The human brain contains the enzymatic machinery to produce it. You are, right now, carrying a compound that would be illegal to possess if extracted from your bloodstream and stored in a vial.
The fact that DMT is endogenous — produced by the body itself — changes everything about how the conversation around it should proceed. It’s not a foreign invader. It’s not something added to normal biology. It’s something the body already makes, and the question is: why?
The Evidence for Endogenous DMT
The story begins with the work of Julius Axelrod, who won the Nobel Prize in Physiology in 1970 for his work on neurotransmitters. In 1961, Axelrod’s lab published a paper demonstrating the presence of the enzyme INMT (indolethylamine N-methyltransferase) in human tissue — the same enzyme required to synthesize DMT from its precursor tryptamine. This established the biochemical pathway for DMT production in the human body.
The detection of actual DMT followed. Over subsequent decades, studies confirmed its presence in human urine (consistent, well-replicated), blood (detected in multiple studies, though at variable concentrations), and cerebrospinal fluid (detected by Strassman’s collaborators at UNM). A 2019 study published in Scientific Reports detected DMT in the visual cortex of live rats, suggesting it may be produced directly in brain tissue.
What the research establishes clearly: the enzymatic capacity to produce DMT is present in human biology, and DMT itself is present in human tissue and body fluids. What it does not yet fully establish is exactly where, in what amounts, under what conditions, and for what purpose.
The Pineal Gland Hypothesis
Rick Strassman, in his 1990 research application and in the theory developed in DMT: The Spirit Molecule, proposed the pineal gland as the likely site of endogenous DMT production under extraordinary conditions — specifically near-death experiences, intense meditation, and the transition between sleep and waking.
The pineal gland has attracted spiritual significance across cultures for millennia. Descartes called it the seat of the soul. Hindus associate it with the third eye. The ancient Egyptians depicted it in their sacred art. It sits at the physical center of the brain, it’s symmetrical where most brain structures aren’t, and it’s one of the last structures to calcify with age. Something about it has always attracted human attention.
Biologically, the pineal is primarily known as the site of melatonin production — the hormone that regulates sleep cycles in response to light. It contains high concentrations of serotonin (the precursor to both melatonin and DMT), has an unusually rich blood supply, and has been found to contain both INMT (the DMT-synthesizing enzyme) and AADC (which works with it in the synthesis pathway).
The 2013 study that found DMT in the rat pineal gland under specific conditions — including during cardiac arrest — provided some of the strongest support yet for Strassman’s hypothesis. Subsequent research has continued to investigate the pineal DMT connection.
The hypothesis remains contested. Some researchers argue that pineal concentrations of precursor enzymes are insufficient to produce behaviorally relevant DMT levels. Others argue the detection studies establish plausibility even if they can’t yet quantify production rates. The honest answer is that we don’t yet know with certainty whether the pineal is a significant DMT production site — but the question is being actively investigated.
What Endogenous DMT Might Explain
If the body produces DMT, and if the brain has specific receptors for it (which it does — DMT acts on sigma-1 receptors, serotonin 5-HT2A receptors, and trace amine receptors among others), then this compound presumably serves some biological function. Several candidates have been proposed:
Near-death experiences. The NDEs documented in cardiac arrest survivors — including perception from outside the body, tunnels, light, encounters with deceased relatives, and consistent cross-cultural phenomenology — are extremely difficult to explain under normal neurological models, since the brain in cardiac arrest has severely reduced electrical activity. If endogenous DMT is released in significant amounts at or near death, it might account for what dying people experience. Several researchers have pursued this connection seriously.
Dream states. DMT is structurally related to melatonin and serotonin, both of which are involved in sleep regulation. Some researchers have hypothesized that endogenous DMT plays a role in REM sleep and the content of dreams. This would explain why dream phenomenology — the vividness, the sense of reality, the encounter with unusual beings — shares qualities with low-dose DMT experiences.
Mystical and peak experiences. Spontaneous mystical experiences, occurring without any external substance, have been reported across human history and cultures. They share phenomenological qualities with DMT experiences: dissolution of the ordinary self, sense of unity, encounter with a loving presence, certainty that what was experienced was more real than ordinary reality. If endogenous DMT mediates these experiences, it would explain their universality and consistency.
Cellular protection. More recent research has examined sigma-1 receptors — one of DMT’s targets — in the context of cellular stress response. Sigma-1 receptor activation appears to have neuroprotective effects. DMT may function partly as a cellular protective agent that’s upregulated under conditions of stress or oxygen deprivation.
The Broader Implication
The most significant implication of endogenous DMT isn’t specific to any one theory. It’s structural.
If the human body produces a compound that, when administered externally, produces some of the most profound alterations of consciousness ever documented — including what appear to be genuine contacts with non-ordinary reality — then consciousness research cannot afford to ignore this compound’s normal function.
The brain didn’t develop DMT receptors by accident. It didn’t develop the enzymatic machinery to produce DMT without purpose. The question of what endogenous DMT does is, at some level, the question of what consciousness normally does at its edges — at death, in dreams, in the depths of meditation, in moments of extreme stress and openness.
That question is now being asked by serious scientists with serious tools. What they find will matter.
For the full picture of what DMT does when administered externally and what the science currently shows, read our complete DMT guide.
Related: